In this study, we demonstrated that MIAT influenced AngII-induced cardiac hypertrophy by regulating the expression of a key m6A RNA methylation enzyme, Ythdf2, and may influence its downstream target genes PPARα/CPT-1a. The gene discussed is CPT1A; the disease is cardiac hypertrophy.